RAC AD HOC GROUP SHOULD ADDRESS CONFLICT OF INTEREST ISSUES, VARMUS SAYS IN RESPONSE TO BIO LETTER; NIH FORMS GENE THERAPY RESEARCH OVERSIGHT COMMITTEE
Executive Summary
Potential conflict of interest issues involving Recombinant DNA Advisory Committee members should be examined by the ad hoc RAC review committee, NIH Director Harold Varmus commented at the group's May 1 meeting.